The improvement of sexual function in dialysis patients undergoing treatment with recombinant erythropoietin r-HuEPO appears to be due to several factors. The correction of anemia with its concomitant amelioration of physical and emotional well-being plays a fundamental role in these patients.
Jerry SpivacL.: Erythropoietin: A brief review. Neph., 52: 289–294, 1989.
2.
Stewart-BentleyM., GansD., HortonR.: Regulation of gonadal function in uremia. Metabolism, 23: 1065–1072, 1974.
3.
FeldmanH., SingerI.: Endocrinology and metabolism in uremia and dialysis: a clinical review. Medicine, 54: 345–376, 1974.
4.
CanaleD., BarsantiniS., MinerviniR.: Human chorionic gonadotropine treatment of male sexual inadequacy in patients affected by chronic renal failure. J. Androl., 120–124, 1984.
5.
RamirezG., O'NeilW.M., BloomerH.A.: Abnormalities in the chronic renal failure. J. Clin. Endocrinol. Metab., 45: 658–661, 1977.
6.
MassryS.G., GoldsteinD.A., ProcciW.R.: On the pathogenesis of sexual disfunction of the uremic male. Proc. EDTA, 17: 139, 1980.
7.
GrezesczakW.: Effects of naloxone administration on endocrine abnormalities in chronic renal failure. Am. J. Nephrol., 93–100, 1977.
8.
Menchini-FabrisG.F., TurchiP., GiorgiP.M., CanaleD.: Diagnosis and treatment of sexual dysfunction in patients affected by chronic renal failure on hemodialysis. Journal Contributions to Nephrology, 77: 24–33, 1990.
